These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38666717)

  • 1. Emerging and traditional 5-α reductase inhibitors and androgen receptor antagonists for male androgenetic alopecia.
    Gupta AK; Talukder M; Williams G
    Expert Opin Emerg Drugs; 2024 Sep; 29(3):251-261. PubMed ID: 38666717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of low-dose oral minoxidil in the management of androgenetic alopecia.
    Gupta AK; Talukder M; Shemer A
    Expert Opin Pharmacother; 2024 Feb; 25(2):139-147. PubMed ID: 38315101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural products for male androgenetic alopecia.
    Gupta AK; Talukder M; Bamimore MA
    Dermatol Ther; 2022 Apr; 35(4):e15323. PubMed ID: 35044013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia.
    Gupta AK; Talukder M; Williams G
    J Dermatolog Treat; 2022 Nov; 33(7):2946-2962. PubMed ID: 35920739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversies in the treatment of androgenetic alopecia: The history of finasteride.
    Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B
    Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dutasteride in Androgenetic Alopecia: An Update.
    Arif T; Dorjay K; Adil M; Sami M
    Curr Clin Pharmacol; 2017; 12(1):31-35. PubMed ID: 28294070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgenetic alopecia; drug safety and therapeutic strategies.
    Motofei IG; Rowland DL; Baconi DL; Tampa M; Sârbu MI; Păunică S; Constantin VD; Bălălău C; Păunică I; Georgescu SR
    Expert Opin Drug Saf; 2018 Apr; 17(4):407-412. PubMed ID: 29363345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety.
    Dhurat R; Sharma A; Rudnicka L; Kroumpouzos G; Kassir M; Galadari H; Wollina U; Lotti T; Golubovic M; Binic I; Grabbe S; Goldust M
    Dermatol Ther; 2020 May; 33(3):e13379. PubMed ID: 32279398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-therapies in androgenetic alopecia: review and clinical experiences.
    Rossi A; Anzalone A; Fortuna MC; Caro G; Garelli V; Pranteda G; Carlesimo M
    Dermatol Ther; 2016 Nov; 29(6):424-432. PubMed ID: 27424565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the treatment of male pattern hair loss.
    York K; Meah N; Bhoyrul B; Sinclair R
    Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
    [No Abstract]   [Full Text] [Related]  

  • 11. A bibliometric analysis of alternative drug therapy options in the treatment of androgenetic alopecia.
    Gupta AK; Taylor D; Ravi SP; Wang T; Talukder M
    J Cosmet Dermatol; 2024 Oct; 23(10):3287-3294. PubMed ID: 38873787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What's New in Therapy for Male Androgenetic Alopecia?
    Saceda-Corralo D; Domínguez-Santas M; Vañó-Galván S; Grimalt R
    Am J Clin Dermatol; 2023 Jan; 24(1):15-24. PubMed ID: 36169916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature.
    Suchonwanit P; Iamsumang W; Leerunyakul K
    J Dermatolog Treat; 2022 Mar; 33(2):643-648. PubMed ID: 32538225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgenetic alopecia: an evidence-based treatment update.
    Varothai S; Bergfeld WF
    Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis.
    Gupta AK; Venkataraman M; Talukder M; Bamimore MA
    JAMA Dermatol; 2022 Mar; 158(3):266-274. PubMed ID: 35107565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential targets in the discovery of new hair growth promoters for androgenic alopecia.
    Jain R; De-Eknamkul W
    Expert Opin Ther Targets; 2014 Jul; 18(7):787-806. PubMed ID: 24873677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date.
    Iamsumang W; Leerunyakul K; Suchonwanit P
    Drug Des Devel Ther; 2020; 14():951-959. PubMed ID: 32184564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.
    Gupta AK; Mays RR; Dotzert MS; Versteeg SG; Shear NH; Piguet V
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2112-2125. PubMed ID: 29797431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of low-dose oral minoxidil with spironolactone versus finasteride or dutasteride in female androgenetic alopecia management.
    Desai DD; Nohria A; Sikora M; Anyanwu N; Shapiro J; Lo Sicco KI
    Arch Dermatol Res; 2024 Sep; 316(9):622. PubMed ID: 39276230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported outcomes of topical finasteride/minoxidil treatment for male androgenetic alopecia: A retrospective study using telemedical data.
    Abeck F; Hansen I; Kött J; Schröder F; Garrahy E; Veneroso J; Rünger A; Torster L; Schneider SW; von Büren J
    J Cosmet Dermatol; 2024 Sep; 23(9):2956-2963. PubMed ID: 38713003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.